Aksa Convertex Sterilants Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-01-2025
- Paid Up Capital ₹ 0.10 M
as on 02-01-2025
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -15.24%
(FY 2022)
- Profit -36.37%
(FY 2022)
- Ebitda -18.32%
(FY 2022)
- Net Worth 9.24%
(FY 2022)
- Total Assets 1.32%
(FY 2022)
About Aksa Convertex Sterilants
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vijay Pendse, Sachin Sharad, Anuradha Kalyanpur, and Two other members serve as directors at the Company.
- CIN/LLPIN
U40106MH2018PTC309431
- Company No.
309431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2018
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aksa Convertex Sterilants?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Pendse  | Director | 15-May-2018 | Current |
| Sachin Sharad | Director | 18-Sep-2018 | Current |
| Anuradha Kalyanpur | Director | 15-May-2018 | Current |
| Sanjeev Durve | Director | 15-May-2018 | Current |
| Amol Kalyanpur | Director | 15-May-2018 | Current |
Financial Performance of Aksa Convertex Sterilants.
Aksa Convertex Sterilants Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 15.24% decrease. The company also saw a substantial fall in profitability, with a 36.37% decrease in profit. The company's net worth moved up by a moderate rise of 9.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aksa Convertex Sterilants?
Unlock access to Aksa Convertex Sterilants's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Convertex Gases Private LimitedActive 16 years 8 monthsVijay Pendse and Sachin Sharad are mutual person
Aksa Industrial Process Controls Private LimitedActive 33 years 3 monthsAnuradha Kalyanpur and Amol Kalyanpur are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aksa Convertex Sterilants?
Unlock and access historical data on people associated with Aksa Convertex Sterilants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aksa Convertex Sterilants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aksa Convertex Sterilants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
